Tilray | TRLY - Costo Del Venduto

Prezzo Delle Azioni
9.12
Cambio Giornaliero
-0.15 -1.62%
Mensile
-14.29%
Annuale
891.30%
Q1 Previsione
9.24




Costo Del Venduto Cambiamento Data
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Aurora Cannabis CAD 88.61M 30.53M 2025-12
Avita Medical AUD 3.3M 166K 2025-12
Canopy Growth CAD 53.08M 8.3M 2025-12
Cronos Group USD 28.74M 10.38M 2025-12
Divis Laboratories Ltd INR 10.63B 1.23B 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Moderna USD 452M 245M 2025-12
Organigram Holdings CAD 56.93M 20.53M 2025-12
Organon & Co USD 745M 25M 2025-09
Revvity USD 350.4M 26.05M 2025-12
Tilray USD 164.37M 8.41M 2025-09
Viatris USD 2.56B 167.3M 2025-12
Xeris Pharmaceuticals USD 13.66M 49K 2025-12
Zealand Pharma A/S 410K 5K 2025-06